Trial reportUrogynecology (Philadelphia, Pa.)2026
Home-Based Biofeedback for Fecal Incontinence: A Randomized Clinical Trial.
Trial report in Urogynecology (Philadelphia, Pa.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
importanceAccess to biofeedback, a first-line treatment for fecal incontinence (FI), is limited.
objectiveThe objective of this study was to evaluate whether an 8-week duration of a home-based digital therapeutic pelvic health system to treat FI in women is equivalent to a 16-week duration. STUDY
designWe conducted a single-blind, randomized, equivalence trial in women with FI. Participants were randomized to 8 or 16 weeks of twice-daily exercises using the system and could opt to participate in remote health coaching. The primary outcome was the change in FI severity as measured by the Vaizey score from baseline to 16 weeks. Our target sample size was 15 participants per arm. Paired t test, χ2 test, and McNemar-Bowker test compared differences over time and between groups.
resultsAmong 38 women enrolled, 36 (18 per arm) provided complete data. All received allocated treatment, with a mean adherence of 75.2%. Most participants identified as non-Hispanic White (97.3%), with a mean age of 62.4 ± 15.4 years and a mean body mass index 29.5 ± 8.9. Baseline FI severity was high and improved significantly over time in both groups. Treatment duration of 8 weeks was equivalent to 16 weeks with changes in Vaizey scores that reached the minimal clinically important difference in both groups (-4.7 ± 5.1 vs -4.8 ± 4.5, P = 0.918).
conclusionsFI outcomes improved significantly with a home-based pelvic health system with biofeedback and remote health coaching used for either 8 or 16 weeks, without significant differences between groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.